l-series human antibody array 1000 glass slide kit (RayBiotech inc)
RayBiotech inc is a verified supplier 
RayBiotech inc manufactures this product 
90
Structured Review
RayBiotech inc
l-series human antibody array 1000 glass slide kit
L Series Human Antibody Array 1000 Glass Slide Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/l-series+human+antibody+array+1000+glass+slide+kit/quantibody+human+growth+factor+array+1/pm37115456-55-6-15
Average 90 stars, based on 1 article reviews
L Series Human Antibody Array 1000 Glass Slide Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/l-series+human+antibody+array+1000+glass+slide+kit/quantibody+human+growth+factor+array+1/pm37115456-55-6-15
Average 90 stars, based on 1 article reviews
l-series human antibody array 1000 glass slide kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Extraction:Article Title: Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1. Article Snippet: Background The dysregulation of exosomal microRNAs plays an important role in the progression of hepatocarcinogenesis.. In this study, we investigated the therapeutic potential of synthetic exosomal miR-26a against HCC cells and explored the feasibility of tumor-derived exosomes as drug delivery vehicles.. Methods Proliferation and migration assays were performed to examine the effects of miR-26a on HCC in vitro. Ab Array:Article Title: Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1. Article Snippet: Background The dysregulation of exosomal microRNAs plays an important role in the progression of hepatocarcinogenesis.. In this study, we investigated the therapeutic potential of synthetic exosomal miR-26a against HCC cells and explored the feasibility of tumor-derived exosomes as drug delivery vehicles.. Methods Proliferation and migration assays were performed to examine the effects of miR-26a on HCC in vitro. |